Abiopharma

Clinical trial NCT05963074 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 320 → 333 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05438043 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 500 → 213 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07324616 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-07 3. primary completion date: 2026-05-01 → 2026-04-07 4. enrollment: 32 → 25 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05217446 updates: 1. primary completion date: 2026-06-01 → 2026-06-19 2. enrollment: 107 → 108 participants

Clinical trial NCT06532032: primary completion date: 2026-04-14 → 2026-05-14.

Clinical trial NCT01804686: completion date: 2030-12-31 → 2029-12-31.

Clinical trial NCT06768489: completion date: 2029-01-02 → 2029-01-29.

Clinical trial NCT07387471 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 14 → 16 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06052631 updates: 1. status: RECRUITING → NOT_YET_RECRUITING 2. start date: 2026-08-04 → 2026-08-05

Clinical trial NCT06901531 updates: 1. completion date: 2028-09-30 → 2027-03-31 2. primary completion date: 2028-09-30 → 2027-03-31